Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             31 results found
no title author magazine year volume issue page(s) type
1 Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome Kim, Haesook T.
2015
21 5 p. 873-880
8 p.
article
2 ASBMT News 2015
21 5 p. 956-
1 p.
article
3 Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation Akı, Şahika Zeynep
2015
21 5 p. 948-953
6 p.
article
4 Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity Copland, Ian B.
2015
21 5 p. 934-940
7 p.
article
5 Bone Mineral Density in Children with Fanconi Anemia after Hematopoietic Cell Transplantation Petryk, Anna
2015
21 5 p. 894-899
6 p.
article
6 Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease Beitinjaneh, Amer
2015
21 5 p. 855-859
5 p.
article
7 Content of Endothelial Progenitor Cells in Autologous Stem Cell Grafts Predict Survival after Transplantation for Multiple Myeloma Blix, Egil S.
2015
21 5 p. 840-847
8 p.
article
8 Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma Bachanova, Veronika
2015
21 5 p. 944-948
5 p.
article
9 Editorial Board 2015
21 5 p. A5-
1 p.
article
10 Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation Remberger, Mats
2015
21 5 p. 889-893
5 p.
article
11 Hematopoietic Stem Cell Transplantation in Nodal T Cell Non-Hodgkin Lymphomas: Revisiting the Issues Poston, Jacqueline
2015
21 5 p. 777-779
3 p.
article
12 Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation Bejanyan, Nelli
2015
21 5 p. 926-933
8 p.
article
13 Incidence and Causes of Hospital Readmission in Pediatric Patients after Hematopoietic Cell Transplantation Shulman, David Stephen
2015
21 5 p. 913-919
7 p.
article
14 Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation Harnicar, Stephen
2015
21 5 p. 920-925
6 p.
article
15 Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant Holstein, Sarah A.
2015
21 5 p. 793-798
6 p.
article
16 Masthead 2015
21 5 p. A4-
1 p.
article
17 Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell–Depleted Human Leukocyte Antigen–Matched Sibling Transplantation Chokshi, Puja
2015
21 5 p. 954-955
2 p.
article
18 Mobilization of Hematopoietic Stem Cells with Lenograstim in Healthy Donors: Efficacy and Safety Analysis According to Donor Age Martino, Massimo
2015
21 5 p. 881-888
8 p.
article
19 Monosomal Karyotype at the Time of Diagnosis or Transplantation Predicts Outcomes of Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome Ustun, Celalettin
2015
21 5 p. 866-872
7 p.
article
20 Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft-versus-Host Disease Smith, Sean Robinson
2015
21 5 p. 799-808
10 p.
article
21 National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report Paczesny, Sophie
2015
21 5 p. 780-792
13 p.
article
22 Officers, Directors, and Board Committee Chairs 2015
21 5 p. A6-
1 p.
article
23 Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies Alousi, Amin M.
2015
21 5 p. 906-912
7 p.
article
24 Reevaluation of the Pretransplant Assessment of Mortality Score after Allogeneic Hematopoietic Transplantation Au, Brandon K.C.
2015
21 5 p. 848-854
7 p.
article
25 Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors Calmettes, Claire
2015
21 5 p. 860-865
6 p.
article
26 Role of Donor Activating KIR–HLA Ligand–Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients Nowak, Jacek
2015
21 5 p. 829-839
11 p.
article
27 Role of Natural Killer Cells in Intravenous Immunoglobulin–Induced Graft-versus-Host Disease Inhibition in NOD/LtSz-scidIL2rg−/− (NSG) Mice Gregoire-Gauthier, Joëlle
2015
21 5 p. 821-828
8 p.
article
28 Single-Agent High-Dose Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Human Leukocyte Antigen–Matched Reduced-Intensity Peripheral Blood Stem Cell Transplantation Results in an Unacceptably High Rate of Severe Acute Graft-versus-Host Disease Bradstock, Kenneth F.
2015
21 5 p. 941-944
4 p.
article
29 Table of Contents 2015
21 5 p. A9-A14
nvt p.
article
30 Treatment of Dyslipidemia in Allogeneic Hematopoietic Stem Cell Transplant Patients Marini, Bernard Lawrence
2015
21 5 p. 809-820
12 p.
article
31 Using Fludarabine to Reduce Exposure to Alkylating Agents in Children with Sickle Cell Disease Receiving Busulfan, Cyclophosphamide, and Antithymocyte Globulin Transplant Conditioning: Results of a Dose De-Escalation Trial Horan, John T.
2015
21 5 p. 900-905
6 p.
article
                             31 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands